Latest Articles

Publication Date
The AGCES Classification System for Endometriosis: Integrating Adenomyosis with Genital and Extragenital Staging-An Expert Consensus Framework from the American & Global College of Endometriosis Specialists (AGCES).

Background: Current endometriosis classification systems have important limitations in accurately describing total disease burden and predicting clinical outcomes. Existing staging frameworks often fail to integrate adenomyosis and do not adequately …

Published: April 10, 2026, midnight
Applications open for Title X Family Planning Services Grants (US) - fundsforNGOs

Applications open for Title X Family Planning Services Grants (US) fundsforNGOs

Published: April 9, 2026, 7:38 a.m.
Real-World Implementation of EndoConnect in Brazilian Primary Care: A Formative Study of Usability, Engagement, and Equity in Digital Endometriosis Care.

Endometriosis is a chronic gynecological condition affecting approximately 10% of women of reproductive age worldwide and is associated with chronic pelvic pain, infertility, and reduced quality of life. In Brazil's …

Published: April 4, 2026, midnight
Endometrial organoids to model benign disorders affecting the endometrium.

The endometrium is a highly dynamic and complex tissue lining the uterus, playing a central role in reproductive health. Despite its importance, the pathogenesis of many benign endometrial disorders remains …

Published: March 31, 2026, midnight
With a Record 70 Spots this Year, Team EndoStrong Has Opened Applications for the 2026 NYC Marathon - Endometriosis Foundation of America

With a Record 70 Spots this Year, Team EndoStrong Has Opened Applications for the 2026 NYC Marathon Endometriosis Foundation of America

Published: March 30, 2026, 7:45 p.m.
Harnessing mangroves for epigenetic therapies.

Mangroves are valuable reservoirs of diverse phytochemicals with significant therapeutic potential. Beyond their ecological roles, these bioactive compounds can influence epigenetic mechanisms, heritable changes in gene expression without alterations in …

Published: March 30, 2026, midnight
EndoCyclic New Drug application approved by US FDA for endometriosis treatment - Pharmafile

EndoCyclic New Drug application approved by US FDA for endometriosis treatment Pharmafile

Published: March 25, 2026, 10:58 a.m.
FDA clears ENDO-205 Investigational New Drug application for endometriosis - Contemporary OB/GYN

FDA clears ENDO-205 Investigational New Drug application for endometriosis Contemporary OB/GYN

Published: March 23, 2026, 7:30 p.m.
EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis - BioSpace

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis BioSpace

Published: March 23, 2026, 12:47 p.m.
EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis - PR Newswire

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis PR Newswire

Published: March 23, 2026, 11:30 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!